And more pharma news updates from Pharmalittle.

“The cloud of the Alzheimer’s diagnosis slowly started to lift ... “I’m not about false hope, and I’m not saying that ...

A third of the drugs that are currently being trialled are 'repurposed' medications that are already being used to tackle other diseases, including diabetes and multiple sclerosis ...

The authors concede that the study is small and limited by the open-label design, saying the funding ... result in false hope for patients with inherited forms of Alzheimer's and their families.

Emma Heming Willis, entrepreneur, author and founder of Make Time Wellness, says the future that she and husband Bruce had ...

A federal judge says it was illegal for the Trump administration to cancel several hundred research grants issued by the ...

Haitham Amal, a Christian Israeli, was awarded an academic chair in brain science, funded by the Satell Family Foundation, for his lab’s and two companies’ advances in the field.The post ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears to slow memory loss, giving patients the gift of more time.

A new way to deliver disease-fighting proteins throughout the brain may improve the treatment of Alzheimer's disease and other neurological disorders, according to University of California ...

New research suggests that a common viral infection lurking in as many as 8 out of 10 Americans could increase the risk of Alzheimer’s disease. But there’s a glimmer of hope — scientists ...

MINNEAPOLIS — A new report reveals more than seven million Americans are living with Alzheimer’s ... ‘O.K., I guess it’s smooth sailing from here on.’ I hope.” And that hope is exactly ...

“We have known for a long time that sleep loss is a risk factor for Alzheimer’s disease,” said senior author David M. Holtzman, MD, Professor of Neurology at WashU Medicine. “In this new ...